NCT03312764

Brief Summary

The goal of this randomized controlled trial is to determine the efficacy of a digital diabetes prevention program for improving weight, glucose control, and secondary risk factors among people with prediabetes compared to an enhanced standard care plus wait-list control. Exploratory assessments of implementation facilitators and barriers will also be completed to determine strategies for integrating external diabetes-prevention interventions within healthcare settings.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
598

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 6, 2017

Completed
12 days until next milestone

First Posted

Study publicly available on registry

October 18, 2017

Completed
14 days until next milestone

Study Start

First participant enrolled

November 1, 2017

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2020

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2020

Completed
Last Updated

February 23, 2021

Status Verified

February 1, 2021

Enrollment Period

2.5 years

First QC Date

October 6, 2017

Last Update Submit

February 22, 2021

Conditions

Keywords

PrediabetesObesityIntensive behavioral counselingType 2 Diabetes

Outcome Measures

Primary Outcomes (1)

  • HbA1c reduction

    Change in percent HbA1c

    Baseline and 12 months

Secondary Outcomes (2)

  • Weight loss

    Baseline, 4 months, and 12 months

  • Decreased cardiovascular risk

    Baseline, 4 months, and 12 months

Other Outcomes (1)

  • Implementation Context

    12 months

Study Arms (2)

Online Diabetes Prevention Program

EXPERIMENTAL

Participants will receive access to a 12-month online diabetes prevention program modeled after the CDC DPP curriculum. Participants in the online program receive paced curriculum, access to a live health coach, interactive group message forums, and connected weight scale and activity monitoring devices.

Behavioral: Online diabetes prevention program

Enhanced Standard Care

ACTIVE COMPARATOR

All participants randomized to the standard-care/control group (SC) will be offered the opportunity to attend a single 90-minute diabetes prevention class with a trained health professional (MPH, RD, or related advanced degree). The class will focus on healthful eating based on the current MyPlate recommendations, guidance on gradual increases in moderate intensity physical activity, and action planning to be shared with friends and/or family. Control participants will also be given the opportunity to participate in the online digital intervention upon completion of the 12-month follow-up assessment.

Behavioral: Standard Care

Interventions

Digital delivery of Intensive behavioral counseling for diabetes prevention and healthy lifestyle management. Recipients have access to online curriculum, a live health coach, group-based communication forums, and connected technology to track weight and physical activity.

Online Diabetes Prevention Program
Standard CareBEHAVIORAL

One-on-one or small group sessions with a dietitian or a trained health professional to advise on physical activity, healthful nutrition and risk reduction for diabetes.

Enhanced Standard Care

Eligibility Criteria

Age19 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Receives care at University of Nebraska Medical Center or Nebraska Medicine
  • Age 19 years or older
  • HbA1c 5.7%-6.4%
  • Overweight (BMI 25+ or 22+ if Asian)
  • Planning to reside in recruitment area for next 12 months
  • Able to engage in moderate aerobic physical activity
  • Medically stable
  • Able to provide informed consent
  • Willing to accept random assignment to treatment

You may not qualify if:

  • Diagnosed with Type I or II diabetes
  • Diagnosed with congestive heart failure, coronary artery disease, chronic obstructive pulmonary disease, pulmonary hypertension
  • Diagnosed with dementia or probable Alzheimer's disease
  • Taking oral hypoglycemic agents
  • Participating in a concurrent weight management program or interventional research protocol
  • Unable to engage in physical activity
  • On a prescribed medical diet
  • Had bariatric surgery within the past 3 years or planning surgery within the next 12 months
  • Anti-obesity or diabetes therapy within the preceding 4 months
  • Any mental health condition, including eating disorders or alcohol/substance use, which would preclude full participation
  • Self-report as currently pregnant or within 6 weeks of having given birth (or planning to become pregnant in the next 12 months)
  • Unstable cardiac disease (i.e. heart attack/failure or stroke in the last 6 months, or in cardiac rehabilitation)
  • On dialysis or an active organ transplant list
  • Chronic kidney disease
  • Untreated thyroid disease
  • +2 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Nebraska Medical Center

Omaha, Nebraska, 68198-4365, United States

Location

Related Publications (1)

  • Katula JA, Dressler EV, Kittel CA, Harvin LN, Almeida FA, Wilson KE, Michaud TL, Porter GC, Brito FA, Goessl CL, Jasik CB, Sweet CMC, Schwab R, Estabrooks PA. Effects of a Digital Diabetes Prevention Program: An RCT. Am J Prev Med. 2022 Apr;62(4):567-577. doi: 10.1016/j.amepre.2021.10.023. Epub 2022 Feb 10.

MeSH Terms

Conditions

Prediabetic StateObesityDiabetes Mellitus, Type 2

Interventions

Standard of Care

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Quality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Paul Estabrooks, PhD

    University of Nebraska

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
All study investigators that collect data or analyze the data are prevented from knowing the interventions assigned to individual participants.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Participants are randomly allocated to one of two groups for the duration of the study.
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 6, 2017

First Posted

October 18, 2017

Study Start

November 1, 2017

Primary Completion

April 30, 2020

Study Completion

August 31, 2020

Last Updated

February 23, 2021

Record last verified: 2021-02

Data Sharing

IPD Sharing
Will share

Individual de-identified participant data that underlie the results reported in published manuscripts will be shared.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
The data will be made available beginning 12 months and ending 36 months following article publication.
Access Criteria
Investigators who provide a methodologically sound proposal, and whose proposed use of the data has been approved by the Sponsor of the study will be given access to data. Data will be made available for participant data meta-analyses. Proposals should be directed to research@omadahealth.com. To gain access, requestors will need to sign a data access agreement. For approved proposals, data will be directly sent electronically to the requestor.

Locations